All Brands Owned by Merck & Co.
Merck & Co. owns 11 brands in our database. Browse the complete portfolio of Merck & Co. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Rahway, New Jersey, USA
Brand Portfolio
11 brands
Stock
NYSE: MRK
Filter by Category
Complete Brand Portfolio
Bridion
Owned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Cozaar
Owned by Merck & Co.
Prescription blood pressure medication for treating hypertension and kidney disease, manufactured and marketed by Merck & Co.
Emend
Owned by Merck & Co.
Prescription antiemetic medication for preventing nausea and vomiting caused by chemotherapy, manufactured and marketed by Merck & Co.
Gardasil
Owned by Merck & Co.
Prescription human papillomavirus vaccine for preventing cervical cancer and other HPV-related cancers, manufactured and marketed by Merck & Co.
Isentress
Owned by Merck & Co.
Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.
Januvia
Owned by Merck & Co.
Prescription diabetes medication for treating type 2 diabetes by increasing insulin secretion, manufactured and marketed by Merck & Co.
Keytruda
Owned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Pepcid
Owned by Merck & Co.
Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.
Propecia
Owned by Merck & Co.
Prescription medication for treating male pattern baldness by inhibiting hair loss, manufactured and marketed by Merck & Co.
Singulair
Owned by Merck & Co.
Prescription medication for treating asthma and allergies by reducing inflammation in the airways, manufactured and marketed by Merck & Co.
Vaseretic
Owned by Merck & Co.
Prescription combination medication for treating high blood pressure, manufactured and marketed by Merck & Co.
About Merck & Co.
What does Merck & Co. own?
Merck & Co. owns a portfolio of pharmaceutical products, vaccines, and animal health medicines. Its most significant asset is Keytruda, the world's best-selling prescription medicine approved for more than 40 cancer indications. Other major products include Gardasil (HPV vaccine), Winrevair (pulmonary arterial hypertension), Januvia (diabetes), and Bridion (anesthesia reversal). The Animal Health segment markets veterinary medicines under the Merck Animal Health brand.
Is Merck & Co. publicly traded?
Yes, Merck & Co., Inc. trades on the New York Stock Exchange under ticker symbol MRK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group, BlackRock, and State Street.
What is Merck's annual revenue?
In FY2024, Merck reported worldwide sales of $64.2 billion, a 7% increase from FY2023. The Pharmaceutical segment generated approximately $57.4 billion and the Animal Health segment approximately $5.8 billion. Keytruda alone accounted for approximately $29.5 billion in FY2024 sales.
Who is Merck's CEO?
Robert M. Davis has served as Chairman and Chief Executive Officer of Merck & Co. since 2021, succeeding Kenneth Frazier. Davis has led the company's strategy of building a post-Keytruda pipeline through acquisitions and internal research investment.
Is Merck & Co. the same as Merck KGaA?
No. Merck & Co. (NYSE: MRK) and Merck KGaA (a German company) are entirely separate companies with no ownership relationship. The separation dates to 1917, when the U.S. government seized German-owned assets in America during World War I. Merck & Co. uses the MSD name outside the United States and Canada to avoid confusion with the German Merck entity.
What is Keytruda and why is it important to Merck?
Keytruda (pembrolizumab) is a PD-1 immune checkpoint inhibitor that works by blocking a protein that prevents the immune system from attacking cancer cells. First approved in 2014 for melanoma, it has since been approved for more than 40 cancer indications. In FY2024, Keytruda generated approximately $29.5 billion in global sales, making it the world's best-selling prescription medicine and accounting for roughly 46% of Merck's total worldwide sales.
Stock Information
Competitors to Merck & Co.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2009 | Mass Market | Global | All Genders | |
| Takeda | Japan | 2018 | Mass Market | Asia Pacific | All Genders |
Learn More About Competitors
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Alofisel
Owned by Takeda Pharmaceutical Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Competitive Analysis
Market Positioning: Merck & Co. competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Merck & Co. Brand Portfolio Overview
Merck & Co. maintains a diverse portfolio of 11 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 11 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Merck & Co.provides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Merck & Co.
Latest News About Merck & Co.
Articles About Merck & Co.
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.